Background-Despite the excess risk of mortality in young women (≤55 years of age) after acute myocardial infarction (AMI), little is known about young women's health status (symptoms, functioning, quality of life) during the first year of recovery after an AMI. We examined gender differences in health status over time from baseline to 12 months after AMI. Methods and Results-A total of 3501 AMI patients (67% women) 18 to 55 years of age were enrolled from 103 US and 24 Spanish hospitals. Data were obtained by medical record abstraction and patient interviews at baseline hospitalization and 1 and 12 months after AMI. Health status was measured by generic (Short Form-12) and disease-specific (Seattle Angina Questionnaire) measures. We compared health status scores at all 3 time points and used longitudinal linear mixed-effects analyses to examine the independent effect of gender, adjusting for time and selected covariates. Women had significantly lower health status scores than men at each assessment (all P values <0.0001). After adjustment for time and all covariates, women had Short Form-12 physical/mental summary scores that were −0.96 (95% confidence interval 
Y oung women (≤55 years) presenting with acute myocardial infarction (AMI) represent a unique, high-risk phenotype 1,2 with a significantly higher risk of in-hospital mortality than men of a similar age. 3, 4 However, the health status (symptoms, functioning, quality of life) 5 differences between men and women from the time of their AMI through the following year are poorly understood. Illuminating the differences in aspects of health status is essential to developing tailored strategies to reduce potential gender-based disparities in outcomes.
Clinical Perspective on p 1980
The few published studies show that older women experience greater functional decline and a poorer health-related quality of life at 6 to 12 months after AMI compared with men, [6] [7] [8] [9] [10] [11] but this research has not included a large number of young patients. Moreover, these studies have not compared the health status patterns of young women with those of men during the post-AMI recovery period, which can enable clinicians to know whether the disparity with regard
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June 2, 2015 to mortality also extends to patients' symptoms, function, and quality of life. 11, 12 To address this gap in knowledge, we used data from the Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) study, a prospective study of young women and men hospitalized with AMI, to examine the patterns of recovery in the year after AMI. 13 The specific objectives of this study were to assess gender differences in health status scores at 3 different time points (ie, baseline and 1 and 12 months), including angina symptoms, disease-specific quality of life, and physical and mental functioning; to examine the change in health status from baseline to 12 months to describe the magnitude of recovery by gender; and to examine the independent effect of gender on each health status score from baseline to 12 months, adjusting for time and important covariates. We hypothesized that young women would have a different pattern of recovery from that of men of a similar age. Additionally, we hypothesized that sociodemographic and clinical factors would attenuate many of the underlying differences in health status between women and men.
Methods

Participants and Study Design
Between August 21, 2008 , and May 1, 2012, we enrolled 18-to 55-year-old patients hospitalized with AMI from 103 US and 24 Spanish hospitals into the VIRGO study, called the Infarto de Miocardio en la Mujer Joven (IMJOVEN) in Spain (VIRGO US grant, 5 R01 HL081153-05; VIRGO Spanish grant, 081614). The VIRGO study was designed to investigate factors associated with higher mortality in young women with AMI. 13 Patients were prospectively recruited and enrolled in the VIRGO study, which used a 2:1 female-to-male enrollment design to enrich the study inclusion of young women. Every attempt was made to enroll consecutive young women with an AMI at each center. After 2 women were recruited, the next young man with an AMI was recruited at each site. A total of 6538 patients with AMI were screened at contributing sites, of whom 3572 were eligible and enrolled. The final cohort used in this study consisted of 2985 patients from the United States (2009 women, 976 men) and 516 patients from Spain (340 women, 176 men) for a total of 3501 patients (2349 women, 1152 men).
The VIRGO study has been previously described. 13 In brief, AMI was confirmed by increased cardiac biomarkers (with at least 1 cardiac biomarker above the 99th percentile of the upper reference limit) within 24 hours of admission. We also required additional evidence of acute myocardial ischemia, including at least 1 of the following: symptoms of ischemia, ECG changes indicative of new ischemia (new ST-T changes, new or presumably new left bundlebranch block, or the development of pathological Q waves). Patients must have presented directly to the enrolling site or must have been transferred within the first 24 hours of presentation to ensure that primary clinical decision making occurred at the enrolling site. We excluded patients who were incarcerated, did not speak English or Spanish, were unable to provide informed consent or to be contacted for follow-up, developed elevated cardiac markers because of elective coronary revascularization, or had an AMI as the result of physical trauma. Institutional Review Board approval was obtained at each participating institution, and patients provided informed consent for their study participation, including baseline hospitalization and follow-up interviews.
Data Collection and Study Definitions
We collected patients' baseline characteristics from medical chart abstraction and standardized in-person interviews administered by trained personnel during the index AMI admission. 13 The patient domains collected include detailed information on sociodemographics, cardiac risk factors, noncardiac comorbidities, disease severity, and in-hospital procedures (Table 1) .
In addition to the above variables collected from the medical record abstraction, in-hospital and 1-and 12-month mortality end points were gathered for both the US and Spanish sites. 16 health status instruments were administered to enrolled patients by trained study personnel at baseline and 1-and 12-month interviews. The SF-12 and SAQ have 4-week recall periods, whereas the EQ-5D inquires about patients' current health at the time of the interview.
SF-12 Scale
The SF-12 has been demonstrated to be a valid and reliable instrument and is the most widely used generic health status instrument to quantify patients' mental/physical functional status.
14 This instrument measures overall physical/mental health status through 12 items, which are answered along varying-length Likert scales. Both the SF-12 Physical Component Summary (PCS) and Mental Component Summary (MCS) scores were calculated for this study and range from 0 to 100, with higher scores indicating greater functioning. A score of 50 represents the US population average, with a standard deviation of 10 points. A mean score of ≥5 to 10 is considered clinically significant.
17,18
EQ-5D Scale
The EQ-5D is a standardized measure of health status that provides a simple and generic measure of health for clinical assessment 15 and has been validated in AMI patients. 19 This questionnaire has 2 parts. The first part is a descriptive section that classifies patients into 1 of 243 health states consisting of the following dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/ depression, with each dimension consisting of 3 possible levels (ie, 1-3) representing no problems to extreme problems. The second part is a 20-cm Visual Analog Scale (EQ-VAS) that ranges from best imaginable state to worst state anchored at 100 and 0, respectively, 20 with higher scores indicating better health states. The mean minimally important difference for the EQ-5D utility index score is 0.040 (SD, 0.026).
21,22
The SAQ The SAQ is a 19-item disease-specific health-related quality-of-life measure for patients with coronary artery disease that has demonstrated validity, reliability, and clinical responsiveness 16, 23 and is predictive of mortality and rehospitalization. 24, 25 The 5 clinically relevant domains of the SAQ include physical limitation, angina stability, angina frequency, treatment satisfaction, and quality of life. For the purposes of this study, the physical limitation, angina frequency, treatment satisfaction, and quality-of-life domains were used. Each domain of the SAQ scores range from 0 to 100 points, with higher scores indicating higher levels of functioning, fewer symptoms, and a greater quality of life or treatment satisfaction. A mean difference of >5 points between groups is considered clinically significant. 16 
Statistical Analysis
Frequencies for categorical variables and means with standard deviations or medians with interquartile ranges for continuous variables were calculated. Statistical differences between women and men were determined with χ 2 tests, t tests, and Wilcoxon rank-sum tests as appropriate. Mean scores at baseline and 1 and 12 months were calculated and plotted between women and men for the SF-12, EQ-5D, and SAQ, and the changes from baseline to 12 months were represented as density plots.
To examine the independent effect of gender on health status over time, while taking into account the effect of time, we used longitudinal linear mixed-effects analyses fitted to each health status outcome. 6, 11, 12 This model allows us to examine health status patterns from baseline to 12 months after AMI. We included random effects for the intercept and the slope of time (in which the random effect of the slope of time accounts for the difference in time trend within a patient, and the random effect of the intercept accounts for the effect of the repeated measurements within a patient). 6 For the linear mixedeffects analysis, patients were organized into a multilevel longitudinal structure (patient-time) according to their health score measurements at the 3 time points (ie, baseline and 1 and 12 months).
We first examined female gender alone with the random effect for the intercept in the unadjusted model. We then sequentially adjusted for other important covariates. 26 The first model (adjusted model 1) included female gender and time, with the random effect for the slope of time and intercept. The second model (adjusted model 2) added sociodemographics (age, race, Hispanic origin, and marital status) to model 1 AMI indicates acute myocardial infarction; BMI, body mass index; CABG, coronary artery bypass grafting; CAD, coronary artery disease; GRACE, Global Registry of Acute Coronary Events; IQR, interquartile range; PAD, peripheral artery disease; PCI, percutaneous coronary intervention; SBP, systolic blood pressure; and TIA, transient ischemic attack.
*In Spain, the default race/minority is classified as white, non-Hispanic. 27 score, peak troponin, and presentation within 6 hours) to model 6. In the final model, we assessed the interaction between gender and time to explicitly examine whether the effect of gender on the health status scores changed over time. We reported the parameter estimates and their 95% confidence intervals (CIs), as well as the significance testing of the gender effect in each linear mixed-effects model. Forest plots were used to graphically demonstrate the association of gender with health status throughout these serial stages of adjustment.
All missing data were assumed to be missing at random. For covariates considered in each model, missing values were rare (<3% in the study cohort). For the covariates considered in each model, missing values were imputed as the most common values for categorical variables and as median values for continuous variables. A value of P<0.05 was considered statistically significant. All analyses were done in SAS version 9.3.
Results
Study Sample
At 1 month, 91.8% of women and 91.8% of men were interviewed; at 12 months, 83.0% of women and 80.6% of men were interviewed. Characteristics of those who were interviewed at 12 months versus those who were not interviewed are presented in Table I in the online-only Data Supplement. In brief, those who were interviewed were older, more likely to be white and to have a partner, had more than a high school level of education, and were more likely to be working and to have health insurance. Those who were interviewed were also slightly healthier, having fewer risk factors and comorbidities (ie, smoking, hypertension, diabetes mellitus, previous coronary artery disease/angina, stroke).
Baseline Characteristics
Baseline characteristics of the total sample (n=3501) and stratified by gender (n=2349, 67% women) are shown in Table 1 . The median age was 48 years. The majority of patients in this study had a self-identified race of white, were married, had more than a high school education, worked fulltime, and had private health insurance. The most common risk factor was family history of coronary artery disease, followed by dyslipidemia, hypertension, smoking, obesity, and diabetes mellitus.
Although both genders were of similar age, women were more likely to be black, to be single, to work part-time or not at all, and to have health insurance compared with men. In addition, women were more likely to have diabetes mellitus, obesity, previous stroke/transient ischemic attack, congestive heart failure, renal dysfunction, chronic lung disease, autoimmune disorders, cancer, and depression, but they were less likely to have dyslipidemia or alcohol abuse.
On arrival, women had a higher median heart rate, higher systolic blood pressure, and significantly lower peak troponin levels than men. Women also had a higher GRACE score, were more likely than men to present with a non-ST-segmentelevation myocardial infarction, and were more likely to present to the hospital >6 hours after symptom onset (Table 1) . During their hospitalization, women were significantly less likely to receive primary percutaneous coronary intervention or revascularization procedures (ie, percutaneous coronary intervention, coronary artery bypass grafting) compared with men of a similar age.
Mortality
The 1-month mortality rate was low in women and men (0.5% versus 0.7%; P=0.8). At 1 year, the rates were still low, and women were more likely to die than men, but the difference did not achieve statistical significance (2.3% in women versus 1.4% in men; P=0.10). (Figures 1 and 2 ).
Change in Health Status Scores From Baseline to 12 Months
Although young women had worse health status scores at baseline and 1 and 12 months, the change or magnitude of (Figures 3 and 4) . Specifically, young women reported significantly more change from baseline to 12 months on the physical limitations domain (ie, women gained 10 points compared with only 6 points for men; 10.5±28.7 versus 6.1±21.7; P<0.001).
Independent Effect of Gender on Health Status Scores
Women reported an SF-12 PCS score that was −3.80 points lower than that for men in the unadjusted analysis (95% CI for parameter estimates, −4.51 to −3.09; P<0.001). After adjustment for time and all other covariates (sociodemographics, socioeconomic status, cardiovascular risk factors, medical history, noncardiac comorbidities, and disease severity), women had a PCS score that was −0.96 points lower than that for men (95% CI, −1.59 to −0.32; P=0.003; Figure 5 ). Women also reported a poorer MCS score that was −4.38 points lower than for men in the unadjusted analysis (95% CI, −5.03 to −3.73; P<0.0001). After adjustment, women still had a lower MCS score than men (−2.36 points; 95% CI, −2.99 to −1.72; P<0.001; Figure 5 and Table II in the online-only Data Supplement). Compared with men, women reported a poorer EQ-5D utility index score, which was −7.28 points lower than that for men (95% CI, −8.44 to −6.12; P<0.0001), and a poorer VAS score, which was −4.53 points lower than for men (95% CI, −5.72 to −3.34; P<0.001) in unadjusted analyses. After adjustment, women had a utility index score that was −2.49 points lower than for men (95% CI, −3.57 to −1.42; P<0.001), and although women reported a VAS score that was −1.14 points lower than that for men, this was no longer significant in the final model (95% CI, −2.30 to 0.02; P=0.05; Figure 5 ). In the model that included only gender, women reported an SAQ physical limitations score that was −6.00 points lower than for men in unadjusted analysis (95% CI, −7.14 to −4.86; P<0.001). After adjustment, women had a physical limitations score that was −2.44 points lower than for men (95% CI, −3.53 to −1.34; P<0.001; Figure 6 and Table II in the onlineonly Data Supplement).
Women were also more likely to report having angina, with an SAQ angina frequency score that was −3.47 points lower than for men in unadjusted analyses (95% CI, −4.43 to −2.51; P<0.001). After adjustment, women had an angina frequency score that was −1.03 points lower than for men (95% CI, −1.98 to −0.07; P=0.03; Figure 6 ).
In unadjusted analyses, women reported an SAQ treatment satisfaction score that was −2.33 points lower than for men (95% CI, −3.06 to −1.60; P<0.001). After full adjustment for time and all covariates (sociodemographics, socioeconomic status, cardiovascular risk factors, medical history, noncardiac comorbidities, and disease severity), women continued to have a score that was −1.22 points lower than for men (95% CI, −1.98 to −0.45; P=0.001).
Lastly, in unadjusted analyses, women reported an SAQ quality-of-life score that was −6.56 points lower than for men (95% CI, −7.90 to −5.23; P<0.001). After adjustment for time and all covariates, women still had a score that was −3.51 points lower than that for men (95% CI, −4.80 to −2.22; P<0.001).
In the assessment of the gender-versus-time interaction in the fully adjusted model, there were no significant differences in generic health status scores over time as measured by the SF-12 PCS/MCS or the EQ-5D utility index/VAS score domains or in disease-specific health status as measured by the SAQ angina frequency, treatment satisfaction, and quality-of-life domains except the SAQ physical limitations domain. This suggests that the worse health status experienced by women persists from the time of their AMI through the year after recovery. As an alternative primary analysis to the linear mixed-effects models described above, we used inverse probability weighting and found no meaningful differences between the 2 approaches.
Discussion
We demonstrate that young women with AMI have worse health status outcomes than men of a similar age. Although both genders recover similarly over time with regard to their health status, women have significantly poorer scores than men on all health status domains from baseline to 12 months after AMI. The worse outcomes are similar to the differences present at the time of the AMI, with a similar magnitude of change in health status scores in both genders but no reduction in the worse health status experienced by women from the time of their AMI to 12 months. After adjustment for time and important sociodemographic and clinical variables, women had health status scores that were significantly lower than those for men of a similar age on nearly all measures (ie, women have more angina symptoms, poorer disease-specific quality of life, and poorer physical/mental functioning). These findings show that women have a pattern of health status recovery after AMI similar to that of men. The poorer health status scores observed in women are not entirely explained by the large number of factors prospectively captured in VIRGO. 13 This study extends the previous literature in several important ways. First, this study is the first and largest study of gender differences in health status after admission for AMI in young patients. Second, no previous study has provided such a comprehensive evaluation of health status. The sparse literature on young women with AMI has focused predominantly on in-hospital 3,4,28 and short-term mortality, 29 which alone are insufficient to capture patient experiences after AMI. Understanding the recovery after AMI necessitates examining a wide range of health outcomes over a period of 12 months. The very few longer-term studies have been limited by methodology, the use of mainly generic health status instruments (ie, SF-12), and small sample size, and they did not focus on young women (≤55 years of age). 11, 12, 26, [30] [31] [32] [33] [34] [35] Thus, they do not provide an adequate picture of how younger women, a previously established vulnerable population, recover over time. Third, we were able to demonstrate worse outcomes for women and had, with the male control subjects, the ability to determine whether there were differences in the magnitude of change over time and at baseline hospitalization for AMI. Finally, we were able to show that the effect of female gender remains significant even after adjustment for a range of important confounders, which persists over the year after AMI.
For the first time, we show that young women report significantly poorer physical and mental functioning, more symptoms of angina, and a poorer quality of life over a 12-month period after AMI when compared with men of a similar age. Furthermore, unadjusted health status scores for both genders reached the threshold for what is defined as a clinically relevant difference for the SAQ quality of life, physical limitations, and angina frequency domains but not for the treatment satisfaction domain (ie, mean difference >5 points on the SAQ). 16 Similarly, health status scores reached the threshold for a clinically significant difference on the SF-12 MCS and PCS scores. 17, 18, 36 The study provides novel information that may explain the persistent finding of worse AMI outcomes of young women compared with men. In previous studies focused on mortality and largely conducted >10 years ago, younger women were consistently found to have higher mortality than men. 3, 4, 37 This difference has not been explained by sociodemographic or clinical factors, and thus far, the mechanism underlying this disparity has been unexplained. 1, 2 In our study of AMI survivors, we demonstrate that women have a different health status profile at the time of their AMI. In addition to having a heavier burden of comorbidity, they have worse health status, which largely accounts for the worse outcomes at 12 months. The challenge moving forward is to determine what interventions might prevent deterioration in health status or assist those with a low health status at baseline to improve outcomes.
The mechanism for the poorer health status observed in young women after AMI is not clear. Despite adjustment for a broad range of confounders, women continued to have a poorer health status compared with men, which implies that there may be other potential factors at play. First, this cohort has a substantial burden of disease before the AMI; thus, these events are not occurring in a healthy group, with a greater encumbrance in women. It is probable that hormonal and genetic explanations are at play. 1, 2, 38 Indeed, the association of hormonal status with health status outcomes is an understudied area of research but remains a long-term goal of the VIRGO study. 13 It has previously been demonstrated that young women present with atypical symptoms compared with men 4 and have more complications after AMI such as bleeding events, longer lengths of stay, and more 30-day hospitalizations after the index event, 1, 3, 4 leading to a greater susceptibility to poor outcomes after discharge.
Psychosocial explanations may account, at least in part, for a portion of the gender-based differences in health status. Younger women may have differential lifestyle changes after AMI compared with men, including secondary effects from drugs and prescribed medications and fewer opportunities to attend cardiac rehabilitation programs. 38 Adjusting to a new life situation may hamper women's ability to successfully return to work after AMI, 39, 40 likely coupled with greater caregiving demands. 41 This is a concern because caregiving responsibilities have been shown to predict hospitalization and adverse outcomes after a cardiac event. [42] [43] [44] In addition, fewer social supports, together with increased anxiety and a greater inclination to stress, 45, 46 are likely to influence women's health status and recovery after AMI. 38, 47 Collectively, lifestyle changes, return to work (ie, thus resuming a normal lifestyle), caregiving responsibilities, and the role of social support all warrant further evaluation in future studies of this population.
Study Implications
Our findings indicate that the health status of women is impaired at the time of an AMI and throughout the year of recovery compared with that of men. Improving outcomes may require a combination of attention to their cardiovascular health and any other factors that have impaired their health status in the pre-event setting (ie, smoking, physical inactivity).
Collectively, these findings indicate a better need to understand the outpatient care of young women at risk for AMI.
Limitations
This study should be interpreted in the context of several potential important limitations. First, performing a longitudinal study with patient interviews requires patient consent and participation. As occurs in these studies, some patients were lost to follow-up, and some patients did not respond to requests for a follow-up interview. The percentages, however, were similar for women and men, and this does not appear to have imposed a bias. Second, because this was an observational study, the differences between women and men in health status may be attributable to residual confounding. However, our detailed data collection allowed us to adjust for an extensive range of patient-level factors that are typically not included in gender-based research. Third, because patients were required to be healthy at baseline to participate, the VIRGO cohort was unable to capture those patients who were too ill to be enrolled. Lastly, the mortality rates were quite low in this population, and we lacked statistical power to evaluate differences in outcomes.
Conclusions
Young women with AMI had lower health status at the time of their AMI and 1 and 12 months later compared with men of a similar age. Although both genders recover similarly over time, women have poorer scores than men on all health status measures at each time point. The effect of female gender persists after adjustment for time and an extensive set of potential confounders.
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CLINICAL PERSPECTIVE
For the first time, we have demonstrated that younger women with acute myocardial infarction have worse health status outcomes than men of a similar age. Although both genders recover similarly over time with regard to their health status, women have significantly poorer scores than men on all health status domains from baseline to 12 months after the acute myocardial infarction. The worse outcomes at 12 months in young women are due largely to poorer scores at the time of the acute myocardial infarction, with a similar magnitude of change in health status scores in both genders. After adjustment for time and an extensive set of confounders, women had poorer scores than men on all health status measures, a difference that persisted throughout the entire year after discharge. Improving outcomes for young women may require paying attention to their cardiovascular risk factors and addressing their health status in the pre-event setting. Together, these findings indicate a need to better understand the outpatient care of young women at risk for acute myocardial infarction. Stroke/TIA, prior PAD, history of sleep apnea, congestive heart failure, renal dysfunction).
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Adjusted Model #6= Adjusted Model #5 and non-cardiac co-morbidities (COPD/lung disease, illicit drug use, autoimmune, history of alcohol abuse, depression, cancer).
Adjusted Model #7= Adjusted Model #6 and disease Severity (initial HR, initial SBP, STEMI, ejection fraction <40%, GRACE score, peak troponin, presentation within 6 hours)
